Congress Expands Probe of Prescription-Drug Ads

Quicklink submitted by Amanda Lang     Permalink
Related Topic(s): ; ; ; ; ; ; ; ; ; ; (more...) ; ; ; ; , Add Tags  (less...)

View Ratings | Rate It

Become a Fan
  (9 fans)


The House Energy and Commerce Committee, which has been scrutinizing direct-to-consumer drug advertising for Pfizer's Lipitor, along with Vytorin, jointly marketed by Merck & Co. and Schering-Plough Corp., is expanding its probe to more drugs. Committee Chairman John D. Dingell, D-Mich., and Rep. Bart Stupak, D-Mich., wrote Johnson & Johnson to question whether its ads for the cancer drug Procrit are accurate.

Read the rest of the story HERE:


- Advertisement -
- Advertisement -



The time limit for entering new comments on this Quicklink has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

Comments: Expand   Shrink   Hide  
No comments